FLT1 and neoplasm: Furthermore, VEGFR-2 blockade alone is not sufficient to achieve the maximum therapeutic effect against MPE since tumour-derived VEGF can also promote metastasis via the VEGF/VEGFR-1 signalling pathway [38].